技术与方法 |
|
|
|
|
表达乙肝病毒受体人ASGPR转基因小鼠的建立 |
郭虹敏1,2,吴晓洁2,李想3,周艳荣2,林艳丽2,熊福银2,薛世伟1,陈红星2**陈树林1** |
1.西北农林科技大学动物医学院 杨凌 712100
2. 军事医学科学院生物工程研究所 北京 100071
3.陕西师范大学生命科学学院 西安 710062 |
|
Establishment of the Transgenic Mice Expressing the HBV Receptor Human ASGPR |
GUO Hong-min1,2,WU Xiao-Jie2,LI Xiang3,ZHOU Yan-rong2,LIN Yan-li2,XIONG Fu-yin2,XUE Shi-wei1,CHEN Hong-xing2,CHEN Shu-lin1 |
1.College of Animal Medicine,Northwest A&F University,Yangling 712100,China
2.Institute of Biotechnology , Academy of Military Medical Sciences, Beijing 100071,China
3.College of Life Science,Shannxi Normal University,Xi’an 710062,China |
引用本文:
郭虹敏 吴晓洁 李想 周艳荣 林艳丽 熊福银 薛世伟 陈红星 陈树林. 表达乙肝病毒受体人ASGPR转基因小鼠的建立[J]. 中国生物工程杂志, 2010, 30(05): 87-91.
GUO Gong-Min, TUN Xiao-Ji, LI Xiang, ZHOU Yan-Rong, LIN Yan-Li, XIONG Fu-Yin, XUE Shi-Wei, CHEN Gong-Xing, CHEN Shu-Lin. Establishment of the Transgenic Mice Expressing the HBV Receptor Human ASGPR. China Biotechnology, 2010, 30(05): 87-91.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I05/87
|
[1] Moore P L, Ong S,Harrison T J .Squamous cell carcinoma antigen 1mediated binding of hepatitis B virus to hepatocytes does not involve the hepatic serpin clearance system. J Biol Chem,2003,278:4670946717.
[2] Takeshi K, Shintaro N, Takashi M, et al.Expression of squamous cell carcinoma antigen1 in liver enhances the uptake of hepatitis B virus envelope-derived bionanocapsules in transgenic rats. FEBS Journal,2008,275:57145724.
[3] Treichel U, Meyer zum Büschenfelde K H, et al. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol,1994,75(Pt 11):30213029.
[4] 刘珠果,吴晓洁,周艳荣,等. 表达SARS冠状病毒受体人ACE2转基因小鼠的建立.军事医学科学院院刊,2008,3:211214. Liu Z G,Wu X J,Zhou Y R,et al.Bulletin of the Academy of Military Medical Sciences,2008,3:211214.
[5] Moore K J. Utilization of mouse models in the discovery of human disease genes. Drug Discov Today ,1999,4(3): 123128.
[6] Patterson J B, Manchester M, Oldstone M B. Disease model: dissecting the pathogenesis of the measles virus. Trends Mol Med,2001,7(2): 8588.
[7] Levenbook I, Nomura T.Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice. Lab Anim Sci,1997,47(2):118120.
[8] Wu C H,Ouyang E C.Walton C,et al.Liver cell transplantationnovel animal model for human hepatic viral infections.Croat Med J, 2001, 42 (4): 446450.
[9] Chisari F V, Pinkert C A, Milich D R, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.Science, 1985, 230 (4730): 11571160.
[10] Meier M, Bider M D, Malashkevich V N, et al. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J Mol Biol,2000,300(4): 857865.
[11] Treichel U, MeyerzumBuschenfelde K H, Dienes H P, et al. Receptormediated entry of hepatitis B virus particles into liver cells. Arch Virol,1997,142(3): 493498.
[12] Suzuki T, Suzuki Y. Role of hepatitis B virus surface antigen in HBV infectionfunction of human hepatic sialoglycoprotein as HBV receptor. Nippon Rinsho,1995,53(Suppl):132137.
[13] Neda H, Niitsu Y. Establishment of in vitro model for HBV infection via asialoglycoprotein receptor. Nippon Rinsho,1995,53(Suppl): 121124. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|